Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 10 1997, 2556-2560, Vol 35, No. 10
M Bassiri, PA Mardh and M Domeika
A new PCR kit (AMPLICOR CT/NG; Roche Diagnostic Systems, Inc., Branchburg,
N.J.) was used as a screening tool for the detection of Chlamydia
trachomatis and Neisseria gonorrhoeae in first-void urine (FVU) specimens
from 3,340 asymptomatic women attending European health care units for
contraceptive advice or pregnancy termination. All samples were kept frozen
(-20 degrees C) prior to testing. Chlamydia- positive samples were retested
once by the plasmid-based PCR kit and also by a major outer membrane
protein (MOMP) primer-based PCR. Discrepancies were resolved by using the
direct immunofluorescence test (DIF) with the centrifuged sediment of the
FVU specimens. Samples positive for N. gonorrhoeae were retested by
chromosomal primer-based PCR and verified by a 16S RNA PCR. Of the samples
tested, 1.8% were considered inhibitory by using the internal amplification
control. Of 81 samples positive for C. trachomatis, 74 samples were
positive by both plasmid- and MOMP-based PCRs, 6 samples were positive by
plasmid- based PCR and DIF, and one sample was positive by both MOMP-based
PCR and DIF. Nine samples (0.3%) were positive for N. gonorrhoeae by the
chromosomal primer-based PCR; however, none of the results could be
confirmed. The test offers the unique ability to identify inhibition of
amplification with the optional internal control.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Multiplex AMPLICOR PCR screening for Chlamydia trachomatis and Neisseria gonorrhoeae in women attenting non-sexually transmitted disease clinics. The European Chlamydia Epidemiology Group
Institute of Clinical Bacteriology, Uppsala University, Sweden.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»